報告書 H22-2A-09

Size: px
Start display at page:

Download "報告書 H22-2A-09"

Transcription

1 TEL % 0.5% in vitro QOL Quality of Life 1

2 MCE mpa s Duck Algin 350M M/G C 20% 50 C 1.0% 5 C SV-10 5 C 10 ml E TV 20H model E 1 34 R24 1 ml 5 C rpm s -1 CR-500DX 8 ml 10 ml 37 C 2.0 cm 60 mm/min 2

3 In vitro 1) Viskase Co., Inc. 4 ml 2.67 cm 2 4 ml 37 C 60 strokes/min 244 nm ph ph 6.8 Higuchi 2) Eq.1 Q = 2C 0 ( ) 1 2 Dt π Eq. 1 Q C 0 t D In vivo g Wistar 1 g/kg i.p. 1.0 ml KN-349D 0.5 ml Ameer 3) HPLC AUC 6 MRT 4) 50 C 2.0% 20% 5) 2.0% 20% 2.0% 34.5 C 1.0% 32.0 C Fig C 3

4 6) ph 37 C ph % 0.25% % 2.0% % 2.0% % Fig % 2.0% 0.25, 0.5, 1.0% 37 C 6.07, 5.38, 8.34, kn/m % % Fig. 2) 2.0% 1.0% 2.0% % American Diabetic Association The National Dysphagic Diet Task Force NDD Task Force thin 1 50mPa s nectar-thick mPa s honey-thick mPa s spoon-thick >1750mPa s 7) 50 s -1 Fig s -1 NDD Task Force 0.25% honey-thick 0.5% spoon-thick 0.25% 4

5 0.75% 2.0% 0.5% in vitro Fig. 4A 2.0% 0.5% 2.0% 0.5% 1.0% in vitro 2.0% 2.0% 0.5% 30 1 ph % ph Fig. 4A Higuchi Fig. 4B 2.0% 2.0% 0.5% 2.0% 2.0% 0.5% Fig. 4B cm 2 /s in vivo Fig % 0.5% 2.0% 0.5% 1.0% 1.0 ml Table µg/ml 2.0% 2.0% 0.5% Fig. 5 Table 1 2.0% 0.5% C max t max MRT AUC (0 6h) 130% 5

6 Shimoyama T., Itoh K., Miyazaki S., D Emanuele A., Attwood D., Oral liquid in situ gelling methylcellulose/alginate formulations for sustained drug delivery to dysphagic patients, Drug Dev. Ind. Pharm., submitted. 1. Miyazaki S., Takeuchi S., Yokouchi C., Takada M., Pluronic F-127 gels as a vehicle for topical administration of anticancer agents, Chem. Pharm. Bull., 32, (1984). 2. Higuchi W. I., Analysis of data on the medicament release from ointments, J. Pharm. Sci., 51, (1962). 3. Ameer B., Greenblatt D. J., Divoll M., Abernethy D. R., Shargel L., High-performance liquid chromatographic determination of acetaminophen in plasma: single-dose pharmacokinetic studies, J. Chromatogr., 226, (1981). 4. Yamaoka K., Nagawara T., Uno T., Statistical moments in pharmacokinetics, J. Pharmacokinet. 6

7 Pharmacodyn., 6, (1978). 5. Itoh K., Hatakeyama T., Kimura T., Shimoyama T., Miyazaki S., D Emanuele A., Attwood D., Effect of D-sorbitol on the thermal gelation of methylcellulose formulations for drug delivery, Chem. Pharm. Bull., 58, (2010). 6. Haque A., Jones A. K., Richardson R. K., Morris E. R., Thermal gelation of methylcellulose: mechanism and structures, Carbohydr. Polym., 22, (1993). 7. National Dysphagia Diet Task Force, National Dysphagia Diet: Standardization for Optimal Care, ed. by Clayton J., American Dieteric Association, Chicago,

8 Fig. 1. Effect of alginate concentration on the gelation temperature of 2.0% methylcellulose solution containing 20% sorbitol. Each value is the mean ± S.E. of three determinations. Fig. 2. Shear rate dependence viscosity at 20 C of ( ) 1.0% alginate, ( ) 2.0% methylcellulose, and 2.0% methylcellulose/alginate solutions containing ( ) 0.25% alginate, ( ) 0.5% alginate, ( ) 0.75% alginate, and ( ) 1.0% alginate. Each value is the mean ± S.E. of three determinations. 8

9 Fig. 3. Stress-strain curves of gels of (a) 2.0% methylcellulose, (b) 2.0% methylcellulose/0.25% alginate, (c) 2.0% methylcellulose/0.5% alginate, and (d) 2.0% methylcellulose/1.0% alginate, prepared at 37 C for 24 h. Fig. 4. (A) Cumulative in vitro release of acetaminophen as a function of time and (B) Cumulative in vitro release of paracetamol per unit area, Q, as a function of square root of time from ( ) acetaminophen aqueous solution, ( ) 2.0% methylcellulose, ( ) 0.5% alginate, and ( ) 2.0% methylcellulose/0.5% alginate. Release was into simulated gastric fluid at ph 1.2, for a period of 1 h and subsequently into simulated intestinal fluid at ph 6.8, 37 C. Each value is the mean ± S.E. of four determinations. 9

10 Fig. 5. Plasma concentrations of acetaminophen in rats after oral administration of from ( ) aqueous solution, ( ) 2.0% methylcellulose, ( ) 0.5% alginate, and ( ) 2.0% methylcellulose /0.5% alginate. Each value is the mean ± S.E. of five determinations. * p<0.05, ** p<0.01, 2.0% methylcellulose/0.5% alginate is compared with aqueous solution. p<0.05, p<0.01, 2.0% methylcellulose is compared with aqueous solution. Table 1. Pharmacokinetic parameters of acetaminophen administrated from aqueous solution, methylcellulose gel, alginate gel and methylcellulose/alginate gel formed in situ in rat stomach. Formulation C max (µg/ml) t max (h) AUC (0-6 h) (µg h/ml) MRT (h) AUC formulation AUC aqueous solution Aqueous solution ± ± ± ± % Methylcellulose 4.98 ± 0.94 ** 0.90 ± ± ± 0.13 ** 0.89 ± % Alginate 7.18 ± 0.71 * 0.70 ± ± ± ± % Methylcellulose /0.5% alginate 5.30 ± 0.39 ** 1.60 ± 0.24 ** ± 1.30 ** 2.51 ± 0.11 ** 1.30 ± 0.13 Each value is the mean ± S.E. of five determinations. * p<0.05, ** p<0.01, compared with aqueous solution. 10

Fig. 1. Structures of NM394, NAD-358 and NAD-245 Fig. 2. Typical HPLC chromatograms of NM394 in human plasma by organic solvent extraction method (a): Blank plasma (b): Plasma spiked with NM394 and internal

More information

日本化学療法学会雑誌第51巻第2号

日本化学療法学会雑誌第51巻第2号 piperacillin piperacillin PIPC. g Cmax CL PIPC CL CLR CLNR CL PIPC g g Cmax PIPC Key words: piperacillin Piperacillin PIPC PIPC g g PIPC Cmax g g ml g g ml g g ml T T T PIPC g g T Ccr ml min AUCCmax PIPC

More information

Jan THE JAPANESE JOURNAL OF ANTIBIOTICS XL-1 Table 1. Outline of administering doses, routes and sampling times *: 4 ml/hr/kg Bacillus subtilis

Jan THE JAPANESE JOURNAL OF ANTIBIOTICS XL-1 Table 1. Outline of administering doses, routes and sampling times *: 4 ml/hr/kg Bacillus subtilis THE JAPANESE JOURNAL OF ANTIBIOTICS XL-1 Jan. 1987 Jan. 1987 THE JAPANESE JOURNAL OF ANTIBIOTICS XL-1 Table 1. Outline of administering doses, routes and sampling times *: 4 ml/hr/kg Bacillus subtilis

More information

CHEMOTHERAPY APR Fig. 1 Chemical structure of cefotetan (CTT, YM09330)

CHEMOTHERAPY APR Fig. 1 Chemical structure of cefotetan (CTT, YM09330) CHEMOTHERAPY APR. 1982 Fig. 1 Chemical structure of cefotetan (CTT, YM09330) VOL.30 S-1 CHEMOTHERAPY Fig. 2 Comparison of standard curves of CTT on various test organisms by cylinder plate method Column

More information

CHEMOTHERAPY Fig. 1 Body weight changes of pregnant mice treated orally with AM- 715 Day of sestation

CHEMOTHERAPY Fig. 1 Body weight changes of pregnant mice treated orally with AM- 715 Day of sestation CHEMOTHERAPY CHEMOTHERAPY Fig. 1 Body weight changes of pregnant mice treated orally with AM- 715 Day of sestation CHEMOTHERAPY Table 1 Preliminaly test of AM- 715 1): Mean } SD *: Significant difference

More information

Fig. 1. Structure of [methyl-14c]zonisamide

Fig. 1. Structure of [methyl-14c]zonisamide Key words : Zonisamide, Metabolism, Plasma, Erythrocytes, Preputial gland, Urine, Bile, Rat, Dog, Monkey Metabolism of ["Clzonisamide in rats, dogs and monkeys Katashi MATSUMOTO, Koji YOSHIDA, Toshihiko

More information

untitled

untitled ORYZA OIL & FAT CHEMICAL CO., LTD. WHITE JELLY FUNGUS EXTRACT -P () Ver. 1.3SJ Ver. 1.3SJ 1. 3000 ph 1 Ver. 1.3SJ 1. 1 2. 3 2-1. 2-2. 2-3. 2-4. SOD 3. 7 3-1. in vitro 3-2. in vivo 3-3. in vivo 3-4. in

More information

Vol. 36, Special Issue, S 3 S 18 (2015) PK Phase I Introduction to Pharmacokinetic Analysis Focus on Phase I Study 1 2 Kazuro Ikawa 1 and Jun Tanaka 2

Vol. 36, Special Issue, S 3 S 18 (2015) PK Phase I Introduction to Pharmacokinetic Analysis Focus on Phase I Study 1 2 Kazuro Ikawa 1 and Jun Tanaka 2 Vol. 36, Special Issue, S 3 S 18 (2015) PK Phase I Introduction to Pharmacokinetic Analysis Focus on Phase I Study 1 2 Kazuro Ikawa 1 and Jun Tanaka 2 1 2 1 Department of Clinical Pharmacotherapy, Hiroshima

More information

CHEMOTHERAPY Table 1 Urinary excretion of mezlocillin Fig. 4 Urinary excretion of mezlocillin Fig. 3 Blood levels of mezlocillin

CHEMOTHERAPY Table 1 Urinary excretion of mezlocillin Fig. 4 Urinary excretion of mezlocillin Fig. 3 Blood levels of mezlocillin CHEMOTHERAPY Fig. 2 Urinary excretion of mezlocillin Fig. 1 Blood levels of mezlocillin CHEMOTHERAPY Table 1 Urinary excretion of mezlocillin Fig. 4 Urinary excretion of mezlocillin Fig. 3 Blood levels

More information

VOL. 36 S-3 CHEMOTHERAPY 437

VOL. 36 S-3 CHEMOTHERAPY 437 VOL. 36 S-3 CHEMOTHERAPY 437 438 CHEMOTHERAPY JULY 1988 Fig. 1 Contractile response of gastrointestinal tract to intravenous administration of saline and EM in interdigestive state in dogs (a) : Saline,

More information

coccus aureus Corynebacterium sp, Haemophilus parainfluenzae Klebsiella pneumoniae Pseudornonas aeruginosa Pseudomonas sp., Xanthomonas maltophilia, F

coccus aureus Corynebacterium sp, Haemophilus parainfluenzae Klebsiella pneumoniae Pseudornonas aeruginosa Pseudomonas sp., Xanthomonas maltophilia, F VOL.43 S-1 coccus aureus Corynebacterium sp, Haemophilus parainfluenzae Klebsiella pneumoniae Pseudornonas aeruginosa Pseudomonas sp., Xanthomonas maltophilia, Flavobacter- Table 1. Concentration of grepafloxacin

More information

CHEMOTHERAPY FEB Table 1 Background of volunteers

CHEMOTHERAPY FEB Table 1 Background of volunteers CHEMOTHERAPY FEB. 1985 Table 1 Background of volunteers Table 3 Reproducibility of saisomicln In the EIA and the RIA Fig.1 Comparison of the EIA with the RIA or bioassay of sisomicin Table 4 Blood levels

More information

Table 1. Influence of food deprivation on gastric secretion and severity of ulceration in 18 hr pylorus ligated rats.

Table 1. Influence of food deprivation on gastric secretion and severity of ulceration in 18 hr pylorus ligated rats. Table 1. Influence of food deprivation on gastric secretion and severity of ulceration in 18 hr pylorus ligated rats. Fig. 1. Effects of repeated administrations of several mild antiulcer agents on severity

More information

CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study

CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study VOL. 41 S 1 Table 2. Levels (Đg/ml or Đg/g) of S-1006 in serum, bile, and tissue (gallbladder) after oral administration

More information

Rate of Oxidation of Liquid Iron by Pure Oxygen Shiro BAN-YA and Jae-Dong SHIM Synopsis: The rate of oxidation of liquid iron by oxygen gas has been s

Rate of Oxidation of Liquid Iron by Pure Oxygen Shiro BAN-YA and Jae-Dong SHIM Synopsis: The rate of oxidation of liquid iron by oxygen gas has been s Rate of Oxidation of Liquid Iron by Pure Oxygen Shiro BAN-YA and Jae-Dong SHIM Synopsis: The rate of oxidation of liquid iron by oxygen gas has been studied using a volume constant technique. The process

More information

CHEMOTHERAPY Fig. 1 Chemical structure of CXM-AX

CHEMOTHERAPY Fig. 1 Chemical structure of CXM-AX Fig. 1 Chemical structure of CXM-AX NOV. 1986 Fig. 2 Sensitivity distribution of clinical isolates organisms (106 cells/ml) a Smurcus 27 strains d) P.m irabilis 15 strains b Ecol i 27 strains 111.morganii

More information

Netsu Sokutei 19 (4) Thermal Transitions and Stability of Fatty Acid-Containing and Defatted Bovine Serum Albumin (BSA) Michiko Kodama, Shinji

Netsu Sokutei 19 (4) Thermal Transitions and Stability of Fatty Acid-Containing and Defatted Bovine Serum Albumin (BSA) Michiko Kodama, Shinji Netsu Sokutei 19 (4) 163-169 Thermal Transitions and Stability of Fatty Acid-Containing and Defatted Bovine Serum Albumin (BSA) Michiko Kodama, Shinji Takebayashi, Shun-ichi Kidokoro* and Hatsuho Uedaira**

More information

CHEMOTHERAPY MAY 1988

CHEMOTHERAPY MAY 1988 VOL. 36 NO. 5 Table 1. Subjects studied B. W. Body weight B. H. Body height Abbreviations Ccr Endogenous creatinine clearance PSP Phenolsulfonphthalein test for 15 min BUN Blood urea nitrogen Scr Serum

More information

CHEMOTHERAPY APR. 1984

CHEMOTHERAPY APR. 1984 VOL.32 S-3 CHEMOTHERAPY dihydro-4-oxo-7-(1-piperazinyl)-1, 8-naphthyridine- CHEMOTHERAPY APR. 1984 VOL.32 S-3 CHEMOTHERAPY Table 1 Implantation rates and post- implantation survival rates in females mated

More information

Table 1 Patients with various renal function * Ccr, Creatinine clearance ml/min per 1. 48 m2 ** C.V.D., Cerebral vascular disease ; C.R F., Chronic renal failure ; H.D., Hemoclialysis ; D., Dialyzer ;

More information

CHEMOTHERAPY

CHEMOTHERAPY CHEMOTHERAPY VOL.41 S-2 Laboratory and clinical evaluation of teicoplanin CHEMOTHERAPY AUG. 1993 VOL.41 S-2 Laboratory and clinical evaluation of teicoplanin Table 1. Comparative in vitro activity of teicoplanin

More information

CHEMOTHERAPY SEPT. 1991

CHEMOTHERAPY SEPT. 1991 CHEMOTHERAPY SEPT. 1991 VOL. 39 S-3 Table 1. Background of characteristics and allocation of 9 healthy male volunteers in a single-dose study on betamipron Table 2. Background of characteristics and allocation

More information

日本化学療法学会雑誌第54巻第S-1号

日本化学療法学会雑誌第54巻第S-1号 β β β Key words β β I HP- -CD CHR RHC R R R R CHR R R R R RHC R R R CHR R R R RHC CHR R H CH CH Fig.. Structuralformulaofhydroxypropyl-β -cyclodextrin(hp-β -CD). CH n H β β β β Table-. Dosageandadministration(Singleadministrationstudy)

More information

VOL.39 S-3

VOL.39 S-3 VOL.39 S-3 CHEMOTHERAPY SEPT.1991 Table 1. Background of characteristics and allocation of 5 healthy male volunteers in a multiple-dose study on panipenem/betamipron Day 1 Fig. 1. Schedule of multiple-dose

More information

Regular Articles Jpn. J. Hosp. Pharm. 22(5) (1996) New Oral Dosage Form for Elderly Patients Preparation and Characterization of Gelatin Gel C

Regular Articles Jpn. J. Hosp. Pharm. 22(5) (1996) New Oral Dosage Form for Elderly Patients Preparation and Characterization of Gelatin Gel C Regular Articles Jpn. J. Hosp. Pharm. 22(5) 433-443 (1996) New Oral Dosage Form for Elderly Patients Preparation and Characterization of Gelatin Gel Containing Indigestible Dextrin TAKEHISA HANAWA* õ1,

More information

The Phase Behavior of Monooleoylglycerol-Water Systems Mivoshi Oil & Fat Co.. Ltd. Faculty of Science and Technology, Science University of Tokyo Inst

The Phase Behavior of Monooleoylglycerol-Water Systems Mivoshi Oil & Fat Co.. Ltd. Faculty of Science and Technology, Science University of Tokyo Inst The Phase Behavior of Monooleoylglycerol-Water Systems Mivoshi Oil & Fat Co.. Ltd. Faculty of Science and Technology, Science University of Tokyo Institute of Colloid and Interface Science, Science University

More information

Note; a: Pressure sensor, b: Semi-permeable membrane, c: O-ring, d: Support screen, e: Solution, f: Solvent. Fig. 2. Osmometer cell. Fig. 1. Schematic

Note; a: Pressure sensor, b: Semi-permeable membrane, c: O-ring, d: Support screen, e: Solution, f: Solvent. Fig. 2. Osmometer cell. Fig. 1. Schematic Studies on Collapse of Wood Cells and Negative Pressure in Cell Lumen by Yoshiaki HATTORI* and Yasushi KANAGAWA** The negative pressure, that is liquid-tension, to cause cell-collapse was estimated with

More information

20mg CTD 2.4 2.4 2.4... 5 2.4.1... 5 2.4.2... 7 2.4.3... 10 2.4.4... 13 2.4.5... 18 2.4.6... 20 3 2.4 2.4 2.4.1 JNS002 ( HSPC) N-(Carbonyl-methoxypolyethylene glycol 2000)-1,2- distearoyl-sn-glycero-3-phosphoethanolamine

More information

988 CHEMOTHERAPY NOV. 1971

988 CHEMOTHERAPY NOV. 1971 988 CHEMOTHERAPY NOV. 1971 VOL. 19 NO. 8 CHEMOTHERAPY 989 Effect of medium-ph and inoculum size on activity of SB-PC heart infusion agar, mcg/ml Sensitivity distribution of Staphylococci to SB-PC in surgical

More information

1) Y. Kobuke, K. Hanji, K. Horiguchi, M. Asada, Y. Nakayama, J. Furukawa, J. Am. Chem. Soc., 98, 7414(1976). 2) S. Yoshida, S. Hayano, J. Memb. Sci.,

1) Y. Kobuke, K. Hanji, K. Horiguchi, M. Asada, Y. Nakayama, J. Furukawa, J. Am. Chem. Soc., 98, 7414(1976). 2) S. Yoshida, S. Hayano, J. Memb. Sci., 1) Y. Kobuke, K. Hanji, K. Horiguchi, M. Asada, Y. Nakayama, J. Furukawa, J. Am. Chem. Soc., 98, 7414(1976). 2) S. Yoshida, S. Hayano, J. Memb. Sci., 11, 157(1982). 3) J. D. Lamb, J. J. Christensen, J.

More information

Studies of Foot Form for Footwear Design (Part 9) : Characteristics of the Foot Form of Young and Elder Women Based on their Sizes of Ball Joint Girth

Studies of Foot Form for Footwear Design (Part 9) : Characteristics of the Foot Form of Young and Elder Women Based on their Sizes of Ball Joint Girth Studies of Foot Form for Footwear Design (Part 9) : Characteristics of the Foot Form of Young and Elder Women Based on their Sizes of Ball Joint Girth and Foot Breadth Akiko Yamamoto Fukuoka Women's University,

More information

VOL. 23 NO. 3 CHEMOTHERAPY 1067 Table 2 Sensitivity of gram positive cocci isolated from various diagnostic materials Table 3 Sensitivity of gram nega

VOL. 23 NO. 3 CHEMOTHERAPY 1067 Table 2 Sensitivity of gram positive cocci isolated from various diagnostic materials Table 3 Sensitivity of gram nega 1066 CHEMOTHERAPY MAR. 1975 Table 1 Sensitivity of standard strains VOL. 23 NO. 3 CHEMOTHERAPY 1067 Table 2 Sensitivity of gram positive cocci isolated from various diagnostic materials Table 3 Sensitivity

More information

CHEMOTHERAPY NOV S. aureus, S. epidermidis, E. coli, K. pgeumoniae, E. cloacae, S. marcescens, P. mirabilis, Proteus, P. aeruginosa Inoculum siz

CHEMOTHERAPY NOV S. aureus, S. epidermidis, E. coli, K. pgeumoniae, E. cloacae, S. marcescens, P. mirabilis, Proteus, P. aeruginosa Inoculum siz VOL.33 S-5 CHEMOTHERAPY 381 Fig. 1 Chemical structure of HAPA-B Chemical name 1-N-[(2S)-3-Amino-2-hydroxypropiony1]-4-0-(6-amino- 6-deoxy-a-D-glucopyranosyl)-6-013-deoxy-4-C-methyl- 3-(methylamino)-ƒÀ-L-arabinopyranosyl]-2-deoxystreptamine

More information

Fig. 1 Chemical structure of DL-8280

Fig. 1 Chemical structure of DL-8280 Fig. 1 Chemical structure of DL-8280 Fig. 2 Susceptibility of cl in ical isolates to DL4280 Fig. 5 Susceptibility of clinical isolates to DL-8280 Fig. 3 Susceptibility of clinical isolates to DL-8280 Fig.

More information

CHEMO THER APY Table 1. Background of the volunteers in the phase I clinical trial of ME1207 Table 2. Methods for Phase I clinical trial of ME1207 All doses are expressed in terms of potency as ME1206

More information

CHEMOTHERAPY APRIL 1992 VOL. 40 S- 1 Table 1-1. Comparative in vitro activity of meropenem against clinical isolates CNS: coagulase-negative staphylococci CHEMOTHERAPY APRIL 1992 Table 1-2. Comparative

More information

CHEMOTHERAPY APR. 1982

CHEMOTHERAPY APR. 1982 VOL.30 S-1 CHEMOTHERAPY Table 1 Dose of CTT and subjects i. v.: Intravenous bolus injection d. i. v.: Intravenous drip infusion i. m.: Intramuscular injection Fig. 1 Schedule for examination of CTT, 1.0g

More information

Fig. 1. Schematic drawing of testing system. 71 ( 1 )

Fig. 1. Schematic drawing of testing system. 71 ( 1 ) 1850 UDC 669.162.283 : 669.162.263.24/. 25 Testing Method of High Temperature Properties of Blast Furnace Burdens Yojiro YAMAOKA, Hirohisa HOTTA, and Shuji KAJIKAWA Synopsis : Regarding the reduction under

More information

Effect of Trimoprostil on Gastric Secretion Takeshi KAWAMURA * Hiroko EBINA * Fumiaki KOIZUMI * and Akira ISHIMORI * *Department of Clinical and Labor

Effect of Trimoprostil on Gastric Secretion Takeshi KAWAMURA * Hiroko EBINA * Fumiaki KOIZUMI * and Akira ISHIMORI * *Department of Clinical and Labor Effect of Trimoprostil on Gastric Secretion Takeshi KAWAMURA * Hiroko EBINA * Fumiaki KOIZUMI * and Akira ISHIMORI * *Department of Clinical and Laboratory Medicine University School of Medicine, Tohoku

More information

CHEMOTHERAPY

CHEMOTHERAPY CHEMOTHERAPY Fig.1 Effect of 6059-S on body weight changes in male rats Table 1 Effect of 6059-S on body weight changes in female rats :Mean }S.E. Table 2 Reproductive findings of rats treated with 6059

More information

Table 1. Acute toxicity of Folin on mice. (Litchfield-Wilcoxon method) Numbers in parenthesis indicate 95% fiducial limits. Fig. 1. Analgesic effect of Folin on mice (1% acetic aid-induced writhing). Each

More information

Effect of Sympathetic and parasympathetic agents on cholesterol metabolism in mice salivary glands. Eriko, NEZU and Haruo, NAKAMURA (Department of Ora

Effect of Sympathetic and parasympathetic agents on cholesterol metabolism in mice salivary glands. Eriko, NEZU and Haruo, NAKAMURA (Department of Ora Effect of Sympathetic and parasympathetic agents on cholesterol metabolism in mice salivary glands. Eriko, NEZU and Haruo, NAKAMURA (Department of Oral Physiology, Hokkaido University School of Dentistry,

More information

土木工事共通仕様書(その2)

土木工事共通仕様書(その2) 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 1 2 3 22 578 582 27 4 5 6 567 7 21 8 9 (9), 10 11 12 13 14 (1) (2) 16 532 35 15 (3) (4) (1) (1) 16 (4) () () () 17 () 18 170 19 20 21 10 22 23 24 25 26 27

More information

VOL.32 S-9 CHEMOTHERAPY Table 1 Minimum inhibitory concentrations of AC-1370, CPZ and CAZ Table 2 Efficacy of AC-1370 and CPZ against systemic infections in mice *Inoculum size: 106 cells/ml * 95% confidence

More information

VOL.32 S-7 CHEMOTHERAPY Table 1 MIC of standard strains of CTRX Fig. 2 Cumulative curves of MIC S. aureus (26 strains )

VOL.32 S-7 CHEMOTHERAPY Table 1 MIC of standard strains of CTRX Fig. 2 Cumulative curves of MIC S. aureus (26 strains ) CHEMOTHERAPY OCT. 1984 Fig. I Chemical structure of CTRX VOL.32 S-7 CHEMOTHERAPY Table 1 MIC of standard strains of CTRX Fig. 2 Cumulative curves of MIC S. aureus (26 strains ) CHEMOTHERAPY Fig. 3 Cumulative

More information

Fig. 4. Configuration of fatigue test specimen. Table I. Mechanical property of test materials. Table II. Full scale fatigue test conditions and test

Fig. 4. Configuration of fatigue test specimen. Table I. Mechanical property of test materials. Table II. Full scale fatigue test conditions and test (J. Soc. Mat. Sci., Japan), Vol. 52, No. 11, pp. 1351-1356, Nov. 2003 Fatigue Life Prediction of Coiled Tubing by Takanori KATO*, Miyuki YAMAMOTO*, Isao SAWAGUCHI** and Tetsuo YONEZAWA*** Coiled tubings,

More information

9 Nippon Shokuhin Kagaku Kogaku Kaishi Vol. /,, No.0,,/+,/0 (,**/) 251 * * E#ects of Microbial Transglutaminase on Melting Point and Gel property of G

9 Nippon Shokuhin Kagaku Kogaku Kaishi Vol. /,, No.0,,/+,/0 (,**/) 251 * * E#ects of Microbial Transglutaminase on Melting Point and Gel property of G 9 Nippon Shokuhin Kagaku Kogaku Kaishi Vol. /,, No.0,,/+,/0 (,**/) 251 * * E#ects of Microbial Transglutaminase on Melting Point and Gel property of Gelatins Takahiko Soeda, Tomoko Kaneko*, Akiko Hokazono,

More information

HPLC 1M KH 2 PO 4 ph ml Anthranilic acid: AnA 600 ml ml AnA 1.0 ml / min Anthranilic acid= PRESSURE 140 kgf / cm 2

HPLC 1M KH 2 PO 4 ph ml Anthranilic acid: AnA 600 ml ml AnA 1.0 ml / min Anthranilic acid= PRESSURE 140 kgf / cm 2 15 10-1-3. 1. HPLC 1M KH 2 PO 4 ph 3.0 50 ml Anthranilic acid: AnA 600 ml 1-1. 350 ml AnA 1.0 ml / min Anthranilic acid=137.14 PRESSURE140 kgf / cm 2 TOSOH TSK-GEL ODS- 80 Ts 1) mg / ml AnA in (φ4.6 250

More information

日本化学療法学会雑誌第57巻第S-2号

日本化学療法学会雑誌第57巻第S-2号 µ µ Key words µ µ µ I Table1. Subjectprofilesin(A)singleand(B)multiple-dosestudies (A)Single-dosestudy Age (yr) Height (cm) Bodyweight (kg) BMI (kg/m ) Ccr(Cockcroft) (ml/min) Ethnicity dose(mg) n 5 5.1±.,3

More information

VOL. 34 S-2 CHEMOTH8RAPY 913

VOL. 34 S-2 CHEMOTH8RAPY 913 VOL. 34 S-2 CHEMOTH8RAPY 913 914 CHEMOTHERAPY APR. 1986 Fig. 1 Chemical structure of T-2588 and T-2525 T- 2588 pivaloyloxymethyl (+ )- (6 R, 7 R)-7-[(Z)-2- (2-amino- 4-thiazolyl)-2-methox yiminoacetamido]-3-[(

More information

Key words:fatty acid,plant oil,staphylococcus aureus,skin care, atopic dermatitis

Key words:fatty acid,plant oil,staphylococcus aureus,skin care, atopic dermatitis Key words:fatty acid,plant oil,staphylococcus aureus,skin care, atopic dermatitis growth was monitored at 660 nm with a biophotorecorder. Table 1.Relative inhibitory effects of fatty acids,plant oils,

More information

2 (1) (2) SCI 2 SCI 2 24 2 12 2

2 (1) (2) SCI 2 SCI 2 24 2 12 2 2004 (1) (2) (2) (3) (1) 1 (2) (3) 2 (1) (2) SCI 2 SCI 2 24 2 12 2 100% / 16 2002 2003 http://lin.lin.go.jp/alic/month/dome/1997/nov/chousa.htm (05 612 1315 1618 1922 2329 3039 4049 5059 60 ) =10 b g 1

More information

Time and Temperature Dependence of Recovery Behavior of Residual Strains in Largely Deformed Glassy Poly (Methyl Methacrylate) by Shin'ya YOSHIOKA*, Ryoji NAKAGAWA** and Yukuo NANZAI* Time and temperature

More information

248 Nippon Shokuhin Kagaku Kogaku Kaishi Vol. /-, No./,,.2,/. (,**0) 12 * * * Microencapsulation of Glutamine with Zein by a Solvent Evaporation Metho

248 Nippon Shokuhin Kagaku Kogaku Kaishi Vol. /-, No./,,.2,/. (,**0) 12 * * * Microencapsulation of Glutamine with Zein by a Solvent Evaporation Metho 248 Nippon Shokuhin Kagaku Kogaku Kaishi Vol. /-, No./,,.2,/. (,**0) 12 * * * Microencapsulation of Glutamine with Zein by a Solvent Evaporation Method in Reverse Multiple Emulsion Masato Tanaka*, Yoshinari

More information

Influence of Material and Thickness of the Specimen to Stress Separation of an Infrared Stress Image Kenji MACHIDA The thickness dependency of the temperature image obtained by an infrared thermography

More information

Caloric Behavior of Chemical Oscillation Reactions Shuko Fujieda (Received December 16, 1996) Chemical oscillation behavior of Belousov- Zhabotinskii

Caloric Behavior of Chemical Oscillation Reactions Shuko Fujieda (Received December 16, 1996) Chemical oscillation behavior of Belousov- Zhabotinskii Caloric Behavior of Chemical Oscillation Reactions Shuko Fujieda (Received December 16, 1996) Chemical oscillation behavior of Belousov- Zhabotinskii (BZ) and Briggs- Rauscher (BR) reactions was followed

More information

udc-2.dvi

udc-2.dvi 13 0.5 2 0.5 2 1 15 2001 16 2009 12 18 14 No.39, 2010 8 2009b 2009a Web Web Q&A 2006 2007a20082009 2007b200720082009 20072008 2009 2009 15 1 2 2 2.1 18 21 1 4 2 3 1(a) 1(b) 1(c) 1(d) 1) 18 16 17 21 10

More information

Lymphatic delivery of anticancer drug by lipid microspheres containing prodrug of 5'-deoxy-5- fluorouridine Lipid microspheres (LM)containing lipophil

Lymphatic delivery of anticancer drug by lipid microspheres containing prodrug of 5'-deoxy-5- fluorouridine Lipid microspheres (LM)containing lipophil Lymphatic delivery of anticancer drug by lipid microspheres containing prodrug of 5'-deoxy-5- fluorouridine Lipid microspheres (LM)containing lipophilic prodrug of 5'-deoxy-5-fluorouridine(5' DFUR), 2',3'-didecanoyl-5'-deoxy-5--fluorouridine(C10-5'-DFUR),

More information

Table 1 Antibacterial spectra of CPM and other antimicrobials against anaerobes Fig. 1 In vitro activity of CPM and other antibiotics against B. fragilis (136 strains) Fig. 2 In vitro activity of CPM and

More information

Jon. J. Hosp. Pharm. 21(1) (1995) l Stability of Thiamine in Intravenous Hyperalimentation Containing Multivitamin KEIICHI ASAHARA*, YASUSHI GOD

Jon. J. Hosp. Pharm. 21(1) (1995) l Stability of Thiamine in Intravenous Hyperalimentation Containing Multivitamin KEIICHI ASAHARA*, YASUSHI GOD Jon. J. Hosp. Pharm. 21(1) 15-21 (1995) l Stability of Thiamine in Intravenous Hyperalimentation Containing Multivitamin KEIICHI ASAHARA*, YASUSHI GODA, YUKI SHIMOMURA, YASUHIRO FUJIWARA, KAZUKO SEGAWA,

More information

Dec. THE JAPANESE JOURNAL OF ANTIBIOTICS XXXVII (45)

Dec. THE JAPANESE JOURNAL OF ANTIBIOTICS XXXVII (45) Dec. THE JAPANESE JOURNAL OF ANTIBIOTICS XXXVII-12 2305(45) 2306(46) THE JAPANESE JOURNAL OF ANTIBIOTICS XXXVII-12 Dec. Dec. THE JAPANESE JOURNAL OF ANTIBIOTICS XXXVII-12 2307(47) 2308(48) THE JAPANESE

More information

Tazobactam Piperacillin Fig. 1. Plasma concentrations of tazobactam and piperacillin in animals following a single intravenous administration of tazobactam/piperacillin (10/40 mg/kg). Data represent the

More information

磁気測定によるオーステンパ ダクタイル鋳鉄の残留オーステナイト定量

磁気測定によるオーステンパ ダクタイル鋳鉄の残留オーステナイト定量 33 Non-destructive Measurement of Retained Austenite Content in Austempered Ductile Iron Yoshio Kato, Sen-ichi Yamada, Takayuki Kato, Takeshi Uno Austempered Ductile Iron (ADI) 100kg/mm 2 10 ADI 10 X ADI

More information

untitled

untitled Tl Thallium CAS 7440-28-0 CH 3 COOTl Thallium Acetate CAS 563-68-8 Tl 2 CO 3 Thallium Carbonate CAS 6533-73-9 Tl 2 SO 4 Thallium Sulfate CAS 7446-18-6 TlNO 3 Thallium Nitrate CAS 10102-45-1 TlClO 3 Thallium

More information

1272 CHEMOTHERAPY MAR. 1975

1272 CHEMOTHERAPY MAR. 1975 1272 CHEMOTHERAPY MAR. 1975 VOL. 23 NO. 3 CHEMOTHERAPY 1273 Fig. 2 Minimal inhibitory concentration of aminoglycosides against 50 strains of Klebsiella Fig. 1 Minimal inhibitory concentration of aminoglycosides

More information

S-6.indd

S-6.indd Structural Health Monitoring with Fiber Optic Deformation Sensor ( SOFO ) SOFO SOFO ( SOFO V ) ( SOFO Dynamic ) 2 SOFO The fiber optic deformation sensor, SOFO, has excellent characteristics such as ease

More information

Fig. 1 Mean body weight of pregnant rats administered intravenously with CLM on days 7 to 17 of pregnancy (fetus group) Fig. 2 Mean body weight of female rats administered intravenously with CLM on days

More information

Size Effect of Biomass on Carbonization Rate Treated in Superheated Steam Combined with Far Infrared Heating Akiko ISA Yoshio HAGURA and Kanichi Kit Graduate School of Biosphere Science, Hiroshima University,

More information

Table 1.Concentration of gatifloxacin (Middle-ear) Table 2.Concentration of gatifloxacin (Paranasal sinuses) Table 3.Concentration of gatifloxacin (Tonsil) Table 4.No.of patients studied Table 5.Background

More information

平成26年度 化学物質分析法開発報告書

平成26年度 化学物質分析法開発報告書 N,N- N,N-Dimethylacetamide Acethyldimethylamine CAS 127-19-5 C 4 H 9 NO 87.12 ~ 87.14 87.68413 163-165 C 1) - 18.59 C 2) 1 mg/l 25 C 3) 3.3 hpa 2 C 4) log P ow -.77 2).9429 2/4 C 1) 3.1 4) 1.31E - 8 atm-m

More information

untitled

untitled Application of image correlation technique to determination of in-plane deformation distribution of paper Toshiharu Enomae Graduate School of Agricultural and Life Sciences The University of Tokyo 1 Peters

More information

untitled

untitled 19 11 13 300 18 3 31 1300mg 4 6 C 15 H 22 FN 3 O 6 359.35 + -1-5--β-D--5--1,2--2- -4- 19 11 13 300 18 3 31 A B B A 30 1 2 21 7 1 1 1.31m 2 900mg 1.31m 2 1.64m 2 1,200mg 1.64m 2 1,500mg B 30 1 2 14 7 1

More information

PALL NEWS vol.126 November 2017

PALL NEWS vol.126 November 2017 PALL NEWS November 2017 Vol.126 PALL NEWS vol.126 November 2017 NEW =2000 9660 41.4 MPa 24 MPa NFPA T2.06.01 R2-2001 CAT C/90/* (1x10 6 0-28 MPa 1x10 6 29 120 C 60 C 450 Pa 340 Pa 1 MPa JIS B 8356-3/ISO

More information

(Shigen to Sozai) Vol.116 p (2000) 石炭灰フライアッシュからのゼオライトのアルカリ水熱合成と生成物の陽イオン交換特性 * 1 1 村山憲弘山川洋亮 2 3 小川和男芝田隼次 Alkali Hydrothermal Synthesis of Zeol

(Shigen to Sozai) Vol.116 p (2000) 石炭灰フライアッシュからのゼオライトのアルカリ水熱合成と生成物の陽イオン交換特性 * 1 1 村山憲弘山川洋亮 2 3 小川和男芝田隼次 Alkali Hydrothermal Synthesis of Zeol 石炭灰フライアッシュからのゼオライトのアルカリ水 Title 熱合成と生成物の陽イオン交換特性 Author(s) 村山, 憲弘, 山川, 洋亮, 小川, 和男, 芝田, 隼次 Citation 資源と素材 : 資源 素材学会誌, 116(4): 279-284 Issue Date 2000 URL http://hdl.handle.net/10112/5454 資源 素材学会 (http://www.jstage.jst.go.

More information

VOL. 20 NO. 5 CHEMOTHERAPY Methoxy-4-sulfanilamidopyrimidine (OS-3376) Sulfadimethoxine (SDM) Table 1. In vitro antibacterial activities of OS-3

VOL. 20 NO. 5 CHEMOTHERAPY Methoxy-4-sulfanilamidopyrimidine (OS-3376) Sulfadimethoxine (SDM) Table 1. In vitro antibacterial activities of OS-3 VOL. 20 NO. 5 CHEMOTHERAPY 653 2-Methoxy-4-sulfanilamidopyrimidine (OS-3376) Sulfadimethoxine (SDM) Table 1. In vitro antibacterial activities of OS-3376, SDM, SIZ and SMZ against Gram-positive and negative

More information

スポーツ選手における日常的トレーニングが味覚に及ぼす影響について

スポーツ選手における日常的トレーニングが味覚に及ぼす影響について Study on the Type Partition of Hospital Meals in Japan. -Relationship between Foods and Cooking Techniques- Tomoko WATANABE *1, Kunio ISHII *1, Sachiko SUGIZAKI *1, Kanako MURAMATSU *1, Megumi HIGUCHI

More information

Fig. 1 Structure of a Sebaceous Follicle (Ref.1).

Fig. 1 Structure of a Sebaceous Follicle (Ref.1). Importance and Countermeasures for Sebum Control in Application of Makeup Cosmetics Koichi NOMURA POLA Chemical Industries, Inc., R&D Planning Department 27-1, Takashimadai, Kanagawa-ku, Yokohama 221-0833,

More information

Compatibility of Ophthalmic Solutions õ1 MUTSUMI END0 õ2, NOBUHIRO YASUNO õ2, KAORI TANAGAM1 õ2, ASAKA ONDA õ2, MIHO IMOT0 õ2, NAOMI IIDA õ2, YUKO SEKINE õ2, NORIO MIYAZAKI õ2, SHIGEKAZU WATANABE õ2, YUKO

More information

01-C08244-食品の物性 indd

01-C08244-食品の物性 indd , Vol. 9, No. 3, pp. 123-134, Sep. 2008 Physical Properties of Foods and the Effect of Water on Them II Electrical Properties and Dielectric Relaxation Hitoshi KUMAGAI Department of Food Science and Nutrition,

More information

JAMSTEC Rep. Res. Dev., Volume 12, March 2011, 27 _ 35 1,2* Pb 210 Pb 214 Pb MCA 210 Pb MCA MCA 210 Pb 214 Pb * 2

JAMSTEC Rep. Res. Dev., Volume 12, March 2011, 27 _ 35 1,2* Pb 210 Pb 214 Pb MCA 210 Pb MCA MCA 210 Pb 214 Pb * 2 JAMSTEC Rep. Res. Dev., Volume 12, March 2011, 27 _ 35 1,2* 1 1 1 1 210 Pb 210 Pb 214 Pb MCA 210 Pb MCA MCA 210 Pb 214 Pb 2010 10 4 2010 12 10 1 2 * 237-0061 2-15 046-867-9794 ogurik@jamstec.go.jp 27 210

More information

Corrosion Wear of Alloy Tool Steel (SKD 11) Coated with VC and Precipitation Hardening Stainless Steel (SUS 630) in Sodium Chloride Aqueous Solution T

Corrosion Wear of Alloy Tool Steel (SKD 11) Coated with VC and Precipitation Hardening Stainless Steel (SUS 630) in Sodium Chloride Aqueous Solution T Corrosion Wear of Alloy Tool Steel (SKD 11) Coated with VC and Precipitation Hardening Stainless Steel (SUS 630) in Sodium Chloride Aqueous Solution Toshiyuki TANAKI*, Makoto YUASA** and Isao SEKINE***

More information

X X 1. 1 X 2 X 195 3, 4 Ungár modified Williamson-Hall/Warren-Averbach 5-7 modified modified Rietveld Convolutional Multiple Whole Profile CMWP 8 CMWP

X X 1. 1 X 2 X 195 3, 4 Ungár modified Williamson-Hall/Warren-Averbach 5-7 modified modified Rietveld Convolutional Multiple Whole Profile CMWP 8 CMWP X X a a b b c Characterization of dislocation evolution during work hardening of stainless steels by using XRD line-profile analysis Tomoaki KATO a, Shigeo SATO a, Yoichi SAITO b, Hidekazu TODOROKI b and

More information

特-7.indd

特-7.indd Mechanical Properties and Weldability of Turbine Impeller Materials for High Temperature Exhaust Gas Turbocharger 1 000 1 050 246 IN100 The increase in environmental awareness in recent years has led to

More information

Table 1. Concentration of ritipenem in plasma, gallbladder tissue and bile after ritipenem acoxil administration (200 mg t.i.d., 3 days) N.D.: not det

Table 1. Concentration of ritipenem in plasma, gallbladder tissue and bile after ritipenem acoxil administration (200 mg t.i.d., 3 days) N.D.: not det Table 1. Concentration of ritipenem in plasma, gallbladder tissue and bile after ritipenem acoxil administration (200 mg t.i.d., 3 days) N.D.: not detected *: time after last administration Table 2. Concentration

More information

10生活環境研究報告.indd

10生活環境研究報告.indd It is well known that there are great differences among the flow characteristics of a non- Newtonian fluid such as gelatinized starch dispersions, depending on the analytical devices used and measurement

More information

Key words: E. coli O 157: H7, fosfomycin, verotoxin, mouse infection

Key words: E. coli O 157: H7, fosfomycin, verotoxin, mouse infection Key words: E. coli O 157: H7, fosfomycin, verotoxin, mouse infection Table 1. Bacterial cell counts in feces of mice infected with Esclwrichia coli O 157: H7 NK2 before and during oral dosing with fosfomycin

More information

Fig. 1 Chemical structure of KW-1070

Fig. 1 Chemical structure of KW-1070 Fig. 1 Chemical structure of KW-1070 Fig. 2 Sensitivity distribution of clinical isolates Fig. 4 Sensitivity distribution of clinical isolates Fig. 3 Sensitivity distribution of clinical isolates Fig.

More information

untitled

untitled 1 2 3 4 Alteration of program parameters Effect Increase hybridization temperature Can prevent false positive signals, decrease background, can also increase dynamic range Decrease hybridization temperature

More information

untitled

untitled 1% 1 mg 1 mg 2 CTD 6 Section 2.6.1 Introduction 2.6.1 H 1 descarboethoxyloratadinesch 34117 7.9 SCH 34117 2.6.1-1 O OC 2 H 5 Cl N N JAN Loratadine (JANINN) ethyl 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]

More information

( ) ( ) 87 ( ) 3 ( 150mg/l) cm cm 50cm a 2.0kg 2.0kg

( ) ( ) 87 ( ) 3 ( 150mg/l) cm cm 50cm a 2.0kg 2.0kg 8 12 8 16.2004 1 2 The Effect of Planting Time and Mulching on Chinese Cabbage which to be Harvested from January to February Hitoshi KIMURA,Makoto MIYAGI and Masahito SUZUKI Summary In the cultivation

More information

「諸雑公文書」整理の中間報告

「諸雑公文書」整理の中間報告 30 10 3 from to 10 from to ( ) ( ) 20 20 20 20 20 35 8 39 11 41 10 41 9 41 7 43 13 41 11 42 7 42 11 41 7 42 10 4 4 8 4 30 10 ( ) ( ) 17 23 5 11 5 8 8 11 11 13 14 15 16 17 121 767 1,225 2.9 18.7 29.8 3.9

More information

Fig.1 A location map for the continental ultradeep scientific drilling operations.

Fig.1 A location map for the continental ultradeep scientific drilling operations. Application of a Synthetic Smectite to the Ultradeep Scientific Drilling Operations Makoto KOGA Nitchitsu Co., Ltd. Resources Development Devision, Powder Technological Laboratory 351-1 Kamitano, Arakawa-mura,

More information

A2, Vol. 69, No. 2 Vol. 16, I_237-I_246, Analytical Investigation of Shear Force Distribution of Perfobond Strip with Plural Perforations * ** *

A2, Vol. 69, No. 2 Vol. 16, I_237-I_246, Analytical Investigation of Shear Force Distribution of Perfobond Strip with Plural Perforations * ** * A2, Vol. 69, No. 2 Vol. 16, I_237-I_246, 213. Analytical Investigation of Shear Force Distribution of Perfobond Strip with Plural Perforations * ** *** **** ***** Noriyuki KUBO, Takeshi SAKAI, Shinji OHGUCHI,

More information

Fig. 1. Relation between fatigue crack propagation rate and stress intensity factor range. Fig. 2. Effect of stress ratio on fatigue crack opening rat

Fig. 1. Relation between fatigue crack propagation rate and stress intensity factor range. Fig. 2. Effect of stress ratio on fatigue crack opening rat Fatigue Crack Propagation and Fracture Surface in Polyvinyl Chloride by Tetsuro SHIRAISHI The fatigue crack propagation behavior and the fracture surface appearance under several load conditions in polyvinyl

More information